Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile

Vaccine

Volumn 16, Issue 9-10, 1998, Pages 921-927

  Hoppenbrouwers, K ^a   Lagos, R ^b   Swennen, B ^c   Ethevenaux, C ^d   Knops, J ^a   Levinel, M M ^e   Desmyter, J ^f  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Centro para Vacunas en Desarrollo Chile   (Chile)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d Pasteur Merieux Connaught   (France)

^e UNIVERSITY OF MARYLAND   (United States)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Combined vaccines; Diphtheria tetanus pertussis; Geographic variation of vaccine response; Haemophilus influenzae type b

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; TETANUS TOXOID;

ANOREXIA; ARTICLE; BELGIUM; CHILE; CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG DELIVERY SYSTEM; DRUG SAFETY; EDEMA; ERYTHEMA; FEMALE; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFANT; INTERMETHOD COMPARISON; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PATIENT CODING; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SYRINGE; TETANUS;

ANTIBODIES, BACTERIAL; BELGIUM; CHILE; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; SAFETY; SYRINGES; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 17944396957     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00303-4     Document Type: Article

References (30)

1. 1 Hargreaves, R.M., Slack, M.P., Howard, A.J., Anderson, E. and Ramsay, M.E. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. British Med. J. 1996, 312, 160-161.
2. 2 Centers for Disease Control Progress toward elimination of Haemophilus influenzae type b disease among infants and children - United States, 1993-1994. Morbid. Mortal. Wkly Rep. 1995, 44, 545-550.
3. 3 Peltola, H., Kilpi, T. and Anttila, M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines. Lancet 1992, 340, 592-594.
4. 4 Adams, W.G., Deaver, K.A. and Cochi, S.L. et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. J. Am. Med. Assoc. 1993, 269, 221-226.
5. 5 Fritzell, B. and Plotkin, S. Efficacy and safety of a Haemophilus influenzae type b capsular polysaccharide-tetanus protein conjugate vaccine. J. Pediatr. 1992, 121, 355-362.
6. 6 Ferreccio, C., Clemens, J. and Avendano, A. et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. Pediatr. Infect. Dis. J. 1991, 10, 764-771.
7. 7 Clemens, J.D., Ferreccio, C. and Levine, M.M. et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. J. Am. Med. Assoc. 1992, 267, 673-678.
8. 8 Watemberg, N., Dagan, R. and Arbelli, Y. et al. Safety and immunogenicity of Haemophilus influenzae type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr. Infect. Dis. J. 1991, 10, 758-761.
9. 9 Hoppenbrouwers, K., Roelants, M., Ethevenaux, C., Knops, J. and Desmyter, J. The effect of reconstitution of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) vaccine on the immune response to a diphtheria-tetanus-whole cell pertussis (DTwP) vaccine: a five-year follow-up. In preparation.
10. 10 Greenwood, F.C. and Hunter, W.M. The preparation of 131 iodine labelled human growth hormone of high specific radioactivity. Biochem J. 1963, 89, 114-123.
11. 11 Fayet, M.T., Vincent-Flaquet, J.C., Tayot, J.L. and Trian, R. Interest of the evaluation of tetanus antibodies by RIA. In: Fifth International Conference on Pertussis, Ronely, Sweden, June 18-23, 1978.
12. 12 Kendrick, P.L., Lawson, G.M. and Miller, J.J. Diagnostic Procedures and Reagents. American Public Health Association, New York, 1950, p. 136.
13. 13 Osborn, J.J., Dancis, J. and Julia, J.F. Studies of the immunology of the newborn infant: II. Interference with active immunization by passive circulating antibody. Pediatrics 1952, 10, 328-334.
14. 14 Sangpetchsong, V., Impat, A., Dhiensiri, K. and Podhipak, A. Effect of passive immunity to tetanus in DTP vaccinated infants. Southeast Asian J. Trop. Med. Pub. Hlth 1985, 16, 117-123.
15. 15 Björkholm, B., Granström, M., Taranger, J., Wahl, M. and Hagberg, L. Influence of high titers of maternal antibody on the serologic response of infants to diphtheria vaccination at three, five and twelve months of age. Pediatr. Infect. Dis. J. 1995, 10, 846-850.
16. 16 Habig, W.H. and Tankersley, D.L. Tetanus. In: Vaccines and Immunotherapy (Ed. Cryz, S.J.). Pergamon Press, New York, 1991, pp. 13-19.
17. 17 Brown, G.C., Volk, V.K., Gottshall, R.Y., Kendrick, P.L. and Anderson, H.D. Responses of infants to DTP-P vaccine used in nine injection schedules. Public Health Rep. 1964, 79, 585-602.
18. 18 Avendano, A., Ferreccio, C. and Lagos, R. et al. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age. Pediatr. Infect. Dis. J. 1993, 12, 638-643.
19. 19 Levine, O.S., Granoff, D., Fritzell, B. and Levine, M.M. Factors associated with superior antibody response to a single dose of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age. Vaccine 1997, 15, 325-328.
20. 20 Siber, G., Santosham, M. and Reid, R. et al. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children. N. Engl. J. Med. 1990, 323, 1387-1392.
21. 21 Lenoir, A.A., Pandey, J.P. and Granoff, D.M. Antibody responses of black children to Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein conjugate vaccine in relation to the Km(1) allotype. J. Infect. Dis. 1988, 157, 1242-1254.
22. 22 Granoff, D.M., Pandey, J.P., Boies, E., Squires, J., Munson, R.S. and Suarez, B. Response to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine and risk of Haemophilus meningitis in children with the Km(1) immunoglobulin allotype. J. Clin. Invest. 1984, 74, 1708-1714.
23. 23 Bradshaw, M.W., Schneerson, R., Parke, J.C. and Robbins, J.B. Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b. Lancet 1971, 1, 1095-1096.
24. 24 Schneerson, R. and Robbins, J.B. Induction of serum Haemophilus influenzae type b capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5. N. Engl. J. Med. 1975, 292, 1093-1096.
25. 25 Handzel, Z.T., Argaman, M., Parke, J.C., Schneerson, R. and Robbins, J.B. Heteroimmunization to the capsular polysaccharide of Haemophilus influenzae type b induced by enteric cross-reacting bacteria. Infect. Immun. 1975, 5, 1045-1052.
26. 26 Norden, C.W., Melish, M., Overall, J.C. and Baum, J. Immunologic responses to Haemophilus influenzae meningitis. J. Pediatr. 1972, 80, 209-214.
27. 27 Schneerson, R., Rodrigues, L.P., Parke, J.C. and Robbins, J.B. Immunity to disease caused by Haemophilus influenzae type b: II. Specificity and biologic characteristics of 'natural', infection-acquired, and immunization-induced antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Immunol. 1971, 107, 1081-1089.
28. 28 Greenfield, S., Peter, G., Howie, V., Ploussard, J. and Smith, D. Acquisition of type-specific antibodies to Haemophilus influenzae type b. J. Pediatr. 1972, 80, 204-208.
29. 29 Whisnant, J.K., Rogentine, N., Gralnick, M.A., Schlesselman, J.J. and Robbins, J.B. Host factors and antibody response in Haemophilus influenzae type b meningitis and epiglottitis. J. Infect. Dis. 1976, 133, 448-455.
30. 30 La Scolea, L.J., Rosales, S.V., Welliver, R.C. and Ogra, P.L. Mechanisms underlying the development of meningitis and epiglottitis in children after Haemophilus influenzae type b bacteremia. J. Infect. Dis. 1985, 151, 1162-1165.